Clinical Trials
24 trialsCALPRO
Assistance Publique - Hôpitaux de Paris
THROMBLEUKEMIA
CHU de Reims
REALL CD9
Rennes University Hospital
GATA-2
Institut Claudius Regaud
OPTIFIL
Assistance Publique - Hôpitaux de Paris
MAHATMAt
Assistance Publique Hopitaux De Marseille
PIONEER
Gustave Roussy, Cancer Campus, Grand Paris
SCTMICROBIOM
National Cancer Institute, Slovakia
VISCOTHEM-1
Centre Hospitalier Annecy Genevois
MinimALL
University of Erlangen-Nürnberg Medical School
BIO-TIMER
University Hospital, Clermont-Ferrand
Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk
CHU de Reims
CReSCT
Melbourne Health
PLANET
Centre Leon Berard
DIMATE
Assistance Publique Hopitaux De Marseille
TTV-CART
Institut Paoli-Calmettes
OXYLAM
University Hospital, Toulouse
Interest of a Therapeutic Follow-up of the Cytarabine in the Acute Myeloid Leukaemia: Is There Constitutional Biomarkers
Assistance Publique Hopitaux De Marseille
CCR7-CD4-DPL
University Hospital, Lille
LEA-JA
Institut Paoli-Calmettes
LAM-PTK7
Institut Paoli-Calmettes
Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine
Assistance Publique Hopitaux De Marseille
Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies
Assistance Publique Hopitaux De Marseille
Leukemia Cell Cultures for Research of New Anti-Cancer Therapies
University Hospital, Strasbourg, France